CollPlant Biotechnologies (CLGN) Other Working Capital Changes (2019 - 2025)
CollPlant Biotechnologies' (CLGN) quarterly Other Working Capital Changes came in at -$94000.0 in Q4 2025, up 22.31% YoY from -$76851.4 in Q4 2024, and up 27.69% on a QoQ basis from -$130000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Other Working Capital Changes (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 6 years of Other Working Capital Changes data on file, last reported at -$94000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 22.31% year-over-year to -$94000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$232000.0 (up 64.31% YoY) and the FY2025 annual result came in at -$336000.0, up 48.31% from the prior year.
- Other Working Capital Changes rose to -$94000.0 in Q4 2025, from -$130000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $332000.0 in Q2 2025 to a low of -$508000.0 in Q4 2024.
- A 5-year average of -$7437.5 and a median of $34000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 945.24% — and 2025, when it surged 153.55%.
- Tracing CLGN's Other Working Capital Changes over 5 years: stood at -$337000.0 in 2021, then sank by 171.81% to -$916000.0 in 2022, then surged by 103.38% to $31000.0 in 2023, then plunged by 490.32% to -$121000.0 in 2024, then gained by 22.31% to -$94000.0 in 2025.
- The last three Other Working Capital Changes figures came in at -$94000.0 (Q4 2025), -$130000.0 (Q3 2025), and $113000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | CollPlant Biotechnologies | 4.23 Mn | 4.23 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -286,000.00 |
| Dec 31, 2025 | -286,000.00 |
| Dec 31, 2025 | -286,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Mar 31, 2024 | 137,000.00 |